Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of G-CSF as a Treatment of Toxic Epidermal Necrolysis

NCT02739295 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT02739295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02739295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of G-CSF as a Treatment of Toxic Epidermal Necrolysis
Lead sponsor
University of Liege
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2016
Completion date
March 7, 2023
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stevens - johnson syndrome